Add time:08/30/2019         Source:sciencedirect.com

ObjectiveLiver fibrosis is part of the non-alcoholic fatty liver disease (NAFLD) spectrum, which currently has no approved pharmacological treatment. In this study, we investigated whether supplementation of nicotinamide riboside (NR), a nicotinamide adenine dinucleotide (NAD+) precursor, can reduce the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.

We also recommend Trading Suppliers and Manufacturers of NICOTINAMIDE RIBOSIDE (cas 1341-23-7). Pls Click Website Link as below: cas 1341-23-7 suppliers